+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autism Spectrum Disorder Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4803401
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • Actavis, Inc.
  • Bristol-Myers Squibb
  • Curemark
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
The report on the global autism spectrum disorder therapeutics market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global autism spectrum disorder therapeutics market to grow with a CAGR of 4.4% over the forecast period from 2019-2025. The study on autism spectrum disorder therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on autism spectrum disorder therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global autism spectrum disorder therapeutics market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global autism spectrum disorder therapeutics market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Rising prevalence of autism spectrum disorders
  • Increasing government funding for awareness about the autism spectrum disorder
  • Technological advancement
2) Restraints
  • Stringent regulations for product approval
3) Opportunities
  • Research and innovation happening in autism spectrum disorders therapies
Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global autism spectrum disorder therapeutics market is segmented on the basis of drug class, product type, and distribution channel.

The Global Autism Spectrum Disorder Therapeutics Market by Drug Class
  • Insomnia Drugs
  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Anticonvulsants
  • Antipsychotics
  • Others
The Global Autism Spectrum Disorder Therapeutics Market by Product Type
  • Aripiprazole
  • Risperidone
  • Melatonin
  • CM-AT
  • Bumetanide
  • Balovaptan
The Global Autism Spectrum Disorder Therapeutics Market by Distribution Channel
  • Hospitals
  • Retail Pharmacies
  • Online Channels
Company Profiles
The companies covered in the report include
  • Pediatric Bioscience, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Curemark
  • Actavis, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Novartis AG
  • Bristol-Myers Squibb
  • Merck & Co., Inc.
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the autism spectrum disorder therapeutics market.
2. Complete coverage of all the segments in the autism spectrum disorder therapeutics market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global autism spectrum disorder therapeutics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Actavis, Inc.
  • Bristol-Myers Squibb
  • Curemark
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Autism Spectrum Disorder Therapeutics Market Highlights
2.2. Autism Spectrum Disorder Therapeutics Market Projection
2.3. Autism Spectrum Disorder Therapeutics Market Regional Highlights

3. Global Autism Spectrum Disorder Therapeutics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Drug Class
3.4.2. Growth Matrix Analysis by Product Type
3.4.3. Growth Matrix Analysis by Distribution Channel
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Autism Spectrum Disorder Therapeutics Market

4. Autism Spectrum Disorder Therapeutics Market Macro Indicator Analysis

5. Global Autism Spectrum Disorder Therapeutics Market by Drug Class
5.1. Insomnia Drugs
5.2. Selective Serotonin Reuptake Inhibitors (SSRIs)
5.3. Anticonvulsants
5.4. Antipsychotics
5.5. Others

6. Global Autism Spectrum Disorder Therapeutics Market by Product Type
6.1. Aripiprazole
6.2. Risperidone
6.3. Melatonin
6.4. CM-AT
6.5. Bumetanide
6.6. Balovaptan

7. Global Autism Spectrum Disorder Therapeutics Market by Distribution Channel
7.1. Hospitals
7.2. Retail Pharmacies
7.3. Online Channels

8. Global Autism Spectrum Disorder Therapeutics Market by Region 2019-2025
8.1. North America
8.1.1. North America Autism Spectrum Disorder Therapeutics Market by Drug Class
8.1.2. North America Autism Spectrum Disorder Therapeutics Market by Product Type
8.1.3. North America Autism Spectrum Disorder Therapeutics Market by Distribution Channel
8.1.4. North America Autism Spectrum Disorder Therapeutics Market by Country
8.2. Europe
8.2.1. Europe Autism Spectrum Disorder Therapeutics Market by Drug Class
8.2.2. Europe Autism Spectrum Disorder Therapeutics Market by Product Type
8.2.3. Europe Autism Spectrum Disorder Therapeutics Market by Distribution Channel
8.2.4. Europe Autism Spectrum Disorder Therapeutics Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Autism Spectrum Disorder Therapeutics Market by Drug Class
8.3.2. Asia-Pacific Autism Spectrum Disorder Therapeutics Market by Product Type
8.3.3. Asia-Pacific Autism Spectrum Disorder Therapeutics Market by Distribution Channel
8.3.4. Asia-Pacific Autism Spectrum Disorder Therapeutics Market by Country
8.4. RoW
8.4.1. RoW Autism Spectrum Disorder Therapeutics Market by Drug Class
8.4.2. RoW Autism Spectrum Disorder Therapeutics Market by Product Type
8.4.3. RoW Autism Spectrum Disorder Therapeutics Market by Distribution Channel
8.4.4. RoW Autism Spectrum Disorder Therapeutics Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Autism Spectrum Disorder Therapeutics Market
9.2. Companies Profiles
9.2.1. Pediatric Bioscience, Inc.
9.2.2. Janssen Pharmaceuticals, Inc.
9.2.3. Curemark
9.2.4. Actavis, Inc.
9.2.5. Teva Pharmaceutical Industries Ltd.
9.2.6. Mylan Pharmaceuticals, Inc.
9.2.7. Pfizer Inc.
9.2.8. Novartis AG
9.2.9. Bristol-Myers Squibb
9.2.10. Merck & Co., Inc.

10. Appendix
10.1. Primary Research Findings and Questionnaire

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Pediatric Bioscience, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Curemark
  • Actavis, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Novartis AG
  • Bristol-Myers Squibb
  • Merck & Co., Inc.
Note: Product cover images may vary from those shown
Adroll
adroll